QuadMedicine

At a glance

QuadMedicine filed 53 disclosures in the last 12 months, including 20 insider, 6 5% holder and 1 contract. The most recent key filing was on Oct 26: Director bought 15,000 sh on the market at an average ₩4,279, Oct 20–26.

The 2025 annual report lists 90 employees with an average tenure of 3.9 years and average pay of ₩51.2M, #1395 of 1,829 listed companies by average pay. Its 5 directors and auditors were paid ₩73M each on average. It paid no cash dividend for 2025. 백승기 and related parties held 25.75% at year end.

From the 2025 annual report

Staff: 90 (50 men, 40 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩4.6B. Directors and auditors: 5, paid ₩364M in total.

No cash dividend was paid for 2025.

Largest shareholder

백승기 holds 19.25%; with 8 related parties the group holds 25.75% of common shares at year end (from 30.51% at the start of the year).

Auditor: 동현회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary